 NEW YORK, Aug. 11, 2021 PRNewswire -- Pomerantz LLP announces that a class action lawsuit has been filed against Orphazyme AS Orphazyme or the Company NASDAQ: ORPH and certain of its officers and directors. The class action, filed in the United States District Court for the Northern District of Illinois, Eastern Division, and docketed under 21-cv-03640, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired: a Orphazyme American depositary shares ADSs pursuant andor traceable to the Offering Documents defined below issued in connection with the Companys initial public offering conducted on or about September 29, 2020 the IPO or Offering; andor b Orphazyme securities between September 29, 2020 and June 18, 2021, both dates inclusive the Class Period. 